About Alexander Faje, MD
Alexander Faje, MD is a clinician in the Neuroendocrine Clinical Center and a faculty member in the Neuroendocrine Unit at the Massachusetts General Hospital, and an Instructor of Medicine at Harvard Medical School. He is a clinical researcher and clinician, with a focus on pituitary disease.
Treats:
- Adult
Locations
Mass General Endocrinology: Neuroendocrine & Pituitary Tumor Clinical Center
55 Fruit St.
Boston, MA 02114
Phone: 617-726-7948
Medical Education
- MD, Vanderbilt University School of Medicine
- Residency, University of Michigan Medical Center
- Fellowship, Massachusetts General Hospital*****
American Board Certifications
- Endocrinology, Diabetes & Metabolism, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Accepted Insurance Plans
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Centene/Celticare
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Maine Community Health Options (MCHO)
- Mass General Brigham Health Plan - ACD
- Mass General Brigham Health Plan - PBO
- MassHealth
- Medicare
- Medicare - ACD
- Medicare ACO - ACD
- Medicare ACO - PBO
- OSW - Maine
- OSW - New Hampshire
- Private Health Care Systems (PHCS)
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Publications
-
High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma. Cancer 2018
Dopamine agonists can reduce cystic prolactinomas. J Clin Endocrinol Metab 2016
Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights. Pituitary 2016
Neuroendocrine disorders: pituitary imaging. Handb Clin Neurol 2016
Hypophysitis: evaluation and management. Clin Diabetes Endocrinol 2016
Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma. J Clin Endocrinol Metab 2014
The treatment of hyperprolactinemia in postmenopausal women with prolactin-secreting microadenomas: cons. Endocrine 2014
Central diabetes insipidus: a previously unreported side effect of temozolomide. J Clin Endocrinol Metab 2013
Current treatment options for hyperprolactinemia. Expert Opin Pharmacother 2013
Cavernous carotid artery aneurysm, a rare cause of intrasellar mass and hyperprolactinemia. J Clin Endocrinol Metab 2012
Basal, but not pulsatile, GH secretion determines the ambient circulating levels of IGF-1. J Clin Endocrinol Metab 2010